Lv11
80 积分 2022-02-15 加入
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
1天前
待确认
Recurrent Metastatic Esthesioneuroblastoma: First-in-human α/β PRRT With Actinium-225/Lutetium-177-DOTA-LM3 SSTR Antagonist Achieving Partial Response After Failure of Lutetium-177-DOTATOC PRRT
2天前
已完结
Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
16天前
已完结
Antibody–Drug Conjugates in SCLC: DLL3, B7-H3, TROP2, and Beyond
16天前
已完结
Exatecan Payload-Based Antibody-Drug Conjugates with a Short Hydrophilic Cleavable Linker
21天前
已完结
Computational investigations of flavonoids as ALDH isoform inhibitors for treatment of cancer
26天前
已完结
RELIEVE UCCD: one pathway, two diseases, and a glimpse into the future of IBD trial design
1个月前
已关闭
Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial
1个月前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
1个月前
已完结
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein
1个月前
已关闭
皖公网安备34019202002308
